The FDA said the company did not demonstrate its menthol products provide an added benefit over tobacco flavors.Read More
To date, the agency has authorized 23 new e-cigarette products.Read More
Despite similar state bans, the industry still has flavored products on the market. Read More
Matthew Farrelly is former chief scientist and director of RTI's Center for Health Analytics.Read More
22nd Century partnered with Cannabinoid API Solutions and Transo-Pharm. Read More
The resource center will be continuously updated, according to the FDA.Read More
The most recent U.S. regulatory plan includes “notable changes” from the previous version.Read More
The application now moves on to a preliminary scientific review. Read More
The investigation began after a leading CTP toxicologist disclosed a 2019 memo. Read More
The report found that constant leadership changes created inconsistencies in CTP policies.Read More
